Price T Rowe Associates Inc Fulgent Genetics, Inc. Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
A detailed history of Price T Rowe Associates Inc transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 14,261 shares of FLGT stock, worth $284,221. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,261
Previous 10,803
32.01%
Holding current value
$284,221
Previous $313,000
0.96%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding FLGT
# of Institutions
199Shares Held
14.7MCall Options Held
1.16MPut Options Held
92.9K-
Black Rock Inc. New York, NY3.92MShares$78.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$28.4 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.35MShares$26.8 Million0.01% of portfolio
-
State Street Corp Boston, MA824KShares$16.4 Million0.0% of portfolio
-
Park West Asset Management LLC Larkspur, CA730KShares$14.5 Million1.15% of portfolio
About Fulgent Genetics, Inc.
- Ticker FLGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,265,800
- Market Cap $603M
- Description
- Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...